Clinical Trials Logo

Prostate Cancer clinical trials

View clinical trials related to Prostate Cancer.

Filter by:

NCT ID: NCT05471128 Not yet recruiting - Prostate Cancer Clinical Trials

MRI Fusion Biopsy vs. Micro-Ultrasound Guided Biopsy

Start date: November 2022
Phase:
Study type: Observational

The purpose of this study is to find out how best to detect clinically significant lesions of prostate cancer by using micro-ultrasound technology (ExactVu) and by multiparametric magnetic-resonance imaging (mpMRI).

NCT ID: NCT05470036 Not yet recruiting - Prostate Cancer Clinical Trials

Improving Germline Testing in At-Risk Patients With Prostate Cancer

IMPRINT
Start date: August 2022
Phase: N/A
Study type: Interventional

A quality improvement initiative to improve rates of germline testing among men with prostate cancer through the use of an in-clinic educational session.

NCT ID: NCT05469269 Not yet recruiting - Prostate Cancer Clinical Trials

Cleveland African American Prostate Cancer Project

Start date: October 1, 2022
Phase: N/A
Study type: Interventional

The purpose of this research is to test intervention strategies that encourage and support Black or African American men who are 40 and older to complete prostate cancer screening, and specifically to complete a prostate-specific antigen (PSA) test.

NCT ID: NCT05467176 Not yet recruiting - Prostate Cancer Clinical Trials

A Multi-Center, Prospective, Observational Study of Patients Being Treated With ORGOVYX

OPTYX
Start date: August 31, 2022
Phase:
Study type: Observational

This is a multi-center, prospective, observational study of patients being treated with ORGOVYX. The goal of this study is to generate real-world evidence about the safety and effectiveness of ORGOVYX in patients with prostate cancer in routine clinical care and the clinical course during treatment with and following cessation of ORGOVYX.

NCT ID: NCT05462392 Not yet recruiting - Prostate Cancer Clinical Trials

Robot-assisted Urological Surgeries Using the MicroHand S Robot

Start date: July 2022
Phase: N/A
Study type: Interventional

A single-blinded, prospective randomized parallel controlled clinical trial is designed and will be conducted from July 2022 to November 2023 (anticipated). One hundred and thirty-six patients (anticipated) with renal cancer or bladder cancer or prostate cancer will be enrolled in this study. Those patients will be enrolled by two hospital centers and the patients will be randomly divided into the Micro Hand S surgical robot group and the da Vinci surgical robot group. Robot-assisted partial nephrectomy, radical cystectomy, and radical prostatectomy will be conducted using the Micro Hand S robot or the da Vinci robot. The success rate of operation, assembly time, operation time, intraoperative hemorrhage, continence rate (if applicable), postoperative pain, comprehensive complication index, resident time and surgeon satisfaction were recorded. The aim of the study is to determine whether the newly developed Chinese Micro Hand S surgical robot results in non-inferiority outcomes in urological surgeries compared with the prevalent da Vinci robot.

NCT ID: NCT05458856 Not yet recruiting - Prostate Cancer Clinical Trials

Effects of Triptorelin When Given Every 6-months Under the Skin to Adult Males With Cancer in the Prostate

Start date: July 20, 2022
Phase: Phase 3
Study type: Interventional

The aim of the study is to determine if triptorelin formulated for use every 6 months (given twice during the study) is effective and safe for when given by injection under the skin for the treatment of adult males with cancer in the prostate.

NCT ID: NCT05455736 Recruiting - Prostate Cancer Clinical Trials

STereotactic sAlvage Radiotherapy for Macroscopic Prostate Bed Recurrence After prostatectomy-a Prospective Observational Study

STARR
Start date: March 11, 2021
Phase:
Study type: Observational

STereotactic sAlvage Radiotherapy for macroscopic prostate bed Recurrence after prostatectomy (STARR trial) is a prospective observational study aimed to assess outcome after Stereotactic salvage radiotherapy (SSRT) for macroscopic prostate bed recurrence after radical prostatectomy.

NCT ID: NCT05454488 Recruiting - Prostate Cancer Clinical Trials

An Evidence-Based Focal Cryotherapy Protocol for Focal Ablation of Intermediate Risk Prostate Cancer

Start date: July 25, 2022
Phase: Phase 2
Study type: Interventional

To learn if using cryotherapy to treat only the part of the prostate known to contain cancer is effective in controlling prostate cancer

NCT ID: NCT05454371 Not yet recruiting - Prostate Cancer Clinical Trials

Investigation of Urinary Biomarkers for the Detection of Prostate Cancer

URODETECT-WP2
Start date: December 2022
Phase: N/A
Study type: Interventional

The aim of this study is to investigate and possibly validate urinary biomarkers for prostate cancer. During this study the focus will be on aberrations of selected genes as prognostic or predictive value has been shown for these genes in tissue, CTC or blood derived cfDNA. Proteins will be explored in urine as well. This is a prospective study in which urine samples will be collected from healthy volunteers and urine samples and a blood sample from cancer patients with prostate cancer. The participants will be asked to provide a urine sample collected with the ColliPee® device and fill out an online questionnaire to collect usability data. Thereafter, the urine sample will be aliquoted to be used in the study to investigate the different urinary analytes.

NCT ID: NCT05453604 Recruiting - Breast Cancer Clinical Trials

Evaluation Protocols for Isolation of Analytes From Urine for Future Oncology Applications

URODETECT-WP1
Start date: June 18, 2020
Phase: N/A
Study type: Interventional

The aim of this study is to evaluate and optimize protocols for the isolation and analysis of analytes in urine (cell-free nucleic acids, extracellular vesicles and proteins). The following factors will be evaluated (1) volumetric collection with Colli-Pee®, a collection device developed by Novosanis for standardized collection of urine, and (2) stabilization methods. This is a prospective study in which urine samples will be collected from healthy volunteers, urine samples and a blood sample from pregnant women and cancer patients with solid tumors with emphasis on breast- and prostate cancer. The participants will be asked to provide a urine sample collected with the Colli-Pee® device and fill out an online questionnaire to collect usability data. Thereafter, the urine sample will be aliquoted to be used in different pilot studies for the protocol optimization. For the pilot study where the effect of volume will be assessed, participants will be requested to collect multiple samples with different Colli-Pee® variants and fill out questionnaires accordingly.